Institutional Review Board (IRB)
About the IRB
OHSU members should visit the Institutional Review Board (IRB) page on O2.
The OHSU IRB protects people who participate in research. It reviews studies to ensure they are ethical, safe, and follow laws and OHSU policies. Under the Common Rule (45 CFR Part 46), research is a systematic study to product generalizable knowledge, and a human subjects is a living person whose data or private information are used in research. The IRB can approve studies, request changes, or disapprove them. It also provides guidance to researchers on ethical and regulatory issues.
Interested in becoming an IRB member? Learn more about joining the IRB.
- Consent and Authorization Forms - Knight Cancer Institute (updated January 2026)
- Consent and Authorization Forms - Knight Cancer Institute - Large Format (updated January 2026)
- OHSU IRB Statement of Compliance (updated December 2025)
- Request for Determination (updated December 2025)
- Adverse Event Table for Continuing Review (updated November 2025)
Compliance & Registration
The OHSU IRB operates in compliance and federal, state, and international regulations. For full details, read the OHSU IRB Statement of Compliance.
| Registration Number | Name | Expiration Date |
|---|---|---|
| FWA00000161 | Oregon Hlth & Sci U | 05/17/2028 |
| IRB00000471 | Oregon Hlth & Sci U | 12/19/2028 |
IRB Structure & Fees
IRB reviews are divided among four panels (Panel 1 - 4) from the same membership roster.
Bonnie Nagel, PhD, Interim Chief Research Officer & Executive Vice President, OHSU Research & Innovation is the Institutional Official.
The IRB charges fees for industry-sponsored or funded clinical trials, including those using central or external IRBs. For details, see the IRB Fee Policy.